We are live on ! Find out more
LSBPW

LakeShore Biopharma Warrants
LSBPW

Delisted

LSBPW was delisted on the 19th of September, 2025.

Back to rankings

3 hedge funds and large institutions have $32 invested in LakeShore Biopharma Warrants in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.7% less ownership

Funds ownership: 2.7% → 0% (-2.7%)

84% less funds holding

Funds holding: 19 → 3 (-16)

100% less capital invested

Capital invested by funds: $331K → $32 (-$331K)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 16

Holders
3
Holders Change
-16
Holders Change %
-84.21%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AC
Athos Capital
Hong Kong
-$132K
2
LP
LMR Partners
United Kingdom
-$42K
3
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
-$41.8K
4
VAM
Valliance Asset Management
Hong Kong
-$29.9K
5
Jane Street
Jane Street
New York
-$19.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
HIM
1
HGC Investment Management
Ontario, Canada
$25 – – –
AA
2
Ancora Advisors
Ohio
$7 – – –
LP
3
LMR Partners
United Kingdom
– -$42K -1,052,461 Closed
Toronto Dominion Bank
4
Toronto Dominion Bank
Ontario, Canada
– -$41.8K -1,048,320 Closed
VAM
5
Valliance Asset Management
Hong Kong
– -$29.9K -750,000 Closed
Jane Street
6
Jane Street
New York
– -$19.9K -498,301 Closed
FC
7
Finepoint Capital
Massachusetts
– -$19.6K -489,999 Closed
BCL
8
Bracebridge Capital LLC
Massachusetts
– -$9.27K -232,323 Closed
Calamos Advisors
9
Calamos Advisors
Illinois
– -$5.32K -146,040 Closed
QGA
10
Q Global Advisors
Texas
– -$5K -130,600 Closed
AC
11
Athos Capital
Hong Kong
– -$132K -128,981 Closed
WA
12
Whitebox Advisors
Minnesota
– -$4.99K -125,000 Closed
TSS
13
Two Sigma Securities
New York
– -$4.19K -105,036 Closed
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
– -$4K -100,000 Closed
SCM
15
Saba Capital Management
New York
– -$3.55K -97,299 Closed
Walleye Capital
16
Walleye Capital
New York
– -$3.79K -95,030 Closed
CF
17
Cantor Fitzgerald
New York
– -$3.07K -76,931 Closed
CS
18
Clear Street
New York
– -$1.9K -47,724 Closed

LSBPW Hedge Fund Activity: Q3 2025 in Review

3 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in LakeShore Biopharma Warrants (LSBPW) for Q3 2025, worth a combined $32 — down 100% from $331K a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of LSBPW and 0 opened new positions — a net loss of 16 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Athos Capital, exiting entirely with an estimated $132K sold.

  • 3 institutional investors held LakeShore Biopharma Warrants (LSBPW) as of Q3 2025, down from 19 in Q2 2025.
  • Funds reported $32 of LakeShore Biopharma Warrants stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new LakeShore Biopharma Warrants positions in Q3 2025 and 16 closed out, a net change of -16 holders.
  • The largest LakeShore Biopharma Warrants seller in Q3 2025 was Athos Capital, an estimated $132K sold.

Based on aggregated 13F filings for Q3 2025.